Get the Stockscreener App
17.70
1.14%
0.20
Mediwound Ltd stock is traded at $17.70, with a volume of 114.97K.
It is up +1.14% in the last 24 hours and down -5.55% over the past month.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
See More
Previous Close:
$17.50
Open:
$17.5
24h Volume:
114.97K
Relative Volume:
1.37
Market Cap:
$227.18M
Revenue:
$19.85M
Net Income/Loss:
$-12.75M
P/E Ratio:
-12.83
EPS:
-1.38
Net Cash Flow:
$-21.94M
1W Performance:
+8.92%
1M Performance:
-5.55%
6M Performance:
-15.71%
1Y Performance:
-3.17%
1-Day Range:
$17.21
$18.06
1-Week Range:
$16.26
$18.06
52-Week Range:
$14.14
$22.50
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
17.70 | 224.62M | 19.85M | -12.75M | -21.94M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.41 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
753.55 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
814.74 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
357.98 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.32 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| May-02-25 | Initiated | Alliance Global Partners | Buy |
| Feb-28-25 | Initiated | Craig Hallum | Buy |
| Jul-16-24 | Reiterated | Maxim Group | Buy |
| Dec-22-22 | Initiated | Maxim Group | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Sep-23-20 | Initiated | BTIG Research | Buy |
| Nov-28-16 | Initiated | Aegis Capital | Buy |
| Aug-17-16 | Initiated | Wells Fargo | Outperform |
| Apr-16-14 | Initiated | Oppenheimer | Outperform |
View All
Mediwound Ltd Stock (MDWD) Latest News
How Mediwound Ltd. (MDWD) Affects Rotational Strategy Timing - Stock Traders Daily
Placenta Market Size 2026 Emerging Demands, Share, Trends, - openPR.com
Aug Weekly: What is MediWound Ltds book value per shareJuly 2025 Price Swings & Daily Momentum Trading Reports - baoquankhu1.vn
Meitav Investment House Ltd. Has $5.24 Million Stock Holdings in MediWound Ltd. $MDWD - MarketBeat
MediWound Ltd. (NASDAQ:MDWD) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
MediWound (NASDAQ:MDWD) Share Price Crosses Below Two Hundred Day Moving Average – Time to Sell? - Defense World
MediWound (NASDAQ:MDWD) Share Price Crosses Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat
MediWound Calls February 19, 2026 Extraordinary Meeting to Expand 2024 Share Incentive Plan - TipRanks
MediWound schedules extraordinary general meeting for February 19 - Investing.com
MediWound (NASDAQ: MDWD) seeks vote on 300,000-share incentive pool - Stock Titan
We Think MediWound (NASDAQ:MDWD) Can Afford To Drive Business Growth - Sahm
Short Squeeze: Is MediWound Ltd stock a buy or sell2025 Fundamental Recap & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
(MDWD) and the Role of Price-Sensitive Allocations - Stock Traders Daily
MediWound Lays Out Growth Path With EscharEx Progress, NexoBrid Scale-Up and Strong Cash Position - TipRanks
MediWound (Nasdaq: MDWD) sets 2026–2028 growth outlook and trial goals - Stock Titan
MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare ... - Bluefield Daily Telegraph
MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference - Sahm
MediWound Ltd. (NASDAQ:MDWD) Q3 2025 Earnings Call Transcript - MSN
Will MediWound Ltd. stock deliver long term returnsQuarterly Growth Report & Technical Entry and Exit Tips - Улправда
EBITDA per share of MediWound Ltd. – SWB:M8W - TradingView — Track All Markets
Why MediWound Ltd. stock could be next big winnerJuly 2025 Closing Moves & Accurate Entry/Exit Alerts - Улправда
Is MediWound Ltd. stock supported by strong fundamentalsEarnings Risk Report & Low Risk High Reward Trade Ideas - ulpravda.ru
Is MediWound Ltd. stock attractive for growth ETFsJuly 2025 Big Picture & Free AI Powered Buy and Sell Recommendations - ulpravda.ru
How MediWound Ltd. stock performs in weak economyAnalyst Downgrade & Risk Managed Investment Strategies - Улправда
MediWound Ltd.Ordinary Shares (NQ: MDWD - FinancialContent
MediWound (FRA:M8W) EV-to-OCF : -12.37 (As of Jan. 07, 2026) - GuruFocus
Responsive Playbooks and the MDWD Inflection - Stock Traders Daily
MediWound (NASDAQ:MDWD) Shares Pass Above 50 Day Moving AverageWhat's Next? - MarketBeat
MediWound (NASDAQ:MDWD) Shares Pass Above 50 Day Moving Average – What’s Next? - Defense World
VIX Spike: Why MediWound Ltd stock could be next big winnerMarket Performance Recap & High Return Trade Opportunity Guides - moha.gov.vn
Aug Opening: Will MediWound Ltd stock split attract more investors2025 Earnings Impact & Safe Investment Capital Preservation Plans - Bộ Nội Vụ
MediWound Ltd. (NASDAQ:MDWD) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
MediWound Ltd. (NASDAQ:MDWD) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Liquidity Mapping Around (MDWD) Price Events - Stock Traders Daily
Why MediWound Ltd. stock remains undervaluedWeekly Investment Report & Risk Controlled Swing Alerts - Улправда
What technical signals suggest for MediWound Ltd. stock - Улправда
Aug Sentiment: Is MediWound Ltd. stock attractive for income investorsTrade Entry Summary & Free Community Supported Trade Ideas - Улправда
MediWound Ltd. (NASDAQ:MDWD) is a favorite amongst institutional investors who own 52% - Yahoo Finance
North America Wound Debridement Products Market to See Massive - openPR.com
Why MediWound Ltd. stock is recommended by analystsPortfolio Performance Report & Safe Investment Capital Preservation Plans - Улправда
Support Test: Can MediWound Ltd. stock maintain growth trajectoryWeekly Stock Recap & Momentum Based Trading Ideas - Улправда
Can MediWound Ltd. stock maintain growth trajectoryRate Cut & Free High Return Stock Watch Alerts - Улправда
MediWound (FRA:M8W) EV-to-FCF : -9.79 (As of Jan. 07, 2026) - GuruFocus
MediWound (NASDAQ:MDWD) Stock Passes Above 50-Day Moving Average – What’s Next? - Defense World
MediWound (NASDAQ:MDWD) Stock Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat
MediWound (FRA:M8W) OCF Margin % : -59.66% (As of Sep. 2025) - GuruFocus
Why (MDWD) Price Action Is Critical for Tactical Trading - Stock Traders Daily
MediWound reports NexoBrid reduces traumatic tattoos by over 90% - Investing.com Australia
MediWound Reports New Clinical Data Demonstrating NexoBrid®’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries - GlobeNewswire
MediWound (NASDAQ:MDWD) Stock Crosses Above 50 Day Moving AverageHere's Why - MarketBeat
Short Squeeze: Is MediWound Ltd stock attractive for income investorsPortfolio Performance Report & Consistent Profit Trade Alerts - BỘ NỘI VỤ
Mediwound Ltd Stock (MDWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.92%
2.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):